NAPADISYLATE SALT OF 5-(2-{6-(2,2- DIFLUORO-2- PHENYLETHOXY)HEXY LAMINO}-1- HYDROXYETHYL)-8- HYDROXYQUINOLIN- 2(1H)-ONE AS AGONIST OF THE ß2 ADRENERGIC RECEPTOR

摘要

pThe present invention is directed to crystalline mononapadisylate and/or heminapadisylate salt of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8- hydroxyquinolin-2(1H)-one and pharmaceutically acceptable solvates thereof./p[WO2008095720A1]